Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)

NCT05946148 · clinicaltrials.gov ↗

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Non-Alcoholic Fatty Liver Disease
Liver Steatosis

Interventions

DRUG: Empagliflozin
DRUG: Dulaglutide
DRUG: Control Rx

Sponsor

National and Kapodistrian University of Athens

Collaborators

[object Object]
[object Object]